Zynerba Pharmaceuticals Inc (ZYNE) Insider Trading
- $1,839,387.46
- $183,561.30
- Sept. 13, 2023
- Michael Rapp
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 13, 2023 | Chairman | 17,830 | $1.33 | Sell | $23,713.90 | |
Sept. 13, 2023 | VP | 6,411 | $1.33 | Sell | $8,526.63 | |
Sept. 13, 2023 | CFO | 8,998 | $1.33 | Sell | $11,967.34 | |
Sept. 13, 2023 | Insider | 2,505 | $1.33 | Sell | $3,331.65 | |
Sept. 13, 2023 | President | 12,401 | $1.33 | Sell | $16,493.33 | |
June 14, 2023 | Director | 115 | $0.35 | Sell | $40.25 | |
Jan. 23, 2023 | President | 24,661 | $0.60 | Sell | $14,796.60 | |
Jan. 23, 2023 | Chairman | 35,453 | $0.60 | Sell | $21,271.80 | |
Jan. 23, 2023 | CFO | 17,769 | $0.60 | Sell | $10,661.40 | |
Jan. 23, 2023 | VP | 12,663 | $0.60 | Sell | $7,597.80 | |
July 19, 2022 | CFO | 6,013 | $1.10 | Sell | $6,614.30 | |
July 19, 2022 | CEO | 11,899 | $1.10 | Sell | $13,088.90 | |
July 19, 2022 | VP | 4,289 | $1.10 | Sell | $4,717.90 | |
July 19, 2022 | President | 8,281 | $1.10 | Sell | $9,109.10 | |
June 14, 2022 | Director | 40 | $1.01 | Sell | $40.40 | |
Aug. 22, 2018 | Director | 5,000 | $6.43 | Buy | $32,150.00 | |
Aug. 6, 2018 | Chairman | 15,000 | $5.96 | Buy | $89,400.00 | |
Aug. 6, 2018 | President | 3,800 | $5.79 | Buy | $22,002.00 | |
Aug. 6, 2018 | CFO | 8,518 | $5.97 | Buy | $50,852.46 | |
May 30, 2018 | Major Shareholder | 5,885 | $10.45 | Buy | $61,498.25 | |
May 2, 2018 | Major Shareholder | 15,000 | $10.46 | Buy | $156,900.00 | |
March 22, 2018 | Major Shareholder | 10,000 | $9.28 | Buy | $92,800.00 | |
Jan. 2, 2018 | Major Shareholder | 15,000 | $12.99 | Buy | $194,850.00 | |
Oct. 23, 2017 | Major Shareholder | 25,745 | $9.94 | Buy | $255,905.30 | |
Oct. 19, 2017 | Major Shareholder | 44,255 | $9.59 | Buy | $424,405.45 | |
May 15, 2017 | Chairman | 5,000 | $19.70 | Buy | $98,500.00 | |
May 12, 2017 | CFO | 5,200 | $19.82 | Buy | $103,064.00 | |
Dec. 29, 2016 | Major Shareholder | 10,000 | $15.85 | Buy | $158,500.00 | |
Dec. 7, 2016 | CFO | 7,000 | $14.08 | Buy | $98,560.00 | |
Aug. 16, 2016 | Insider | 3,000 | $10.53 | Sell | $31,590.00 |
Insiders are both buying and selling Zynerba Pharmaceuticals Inc stock.
The insider traders at Zynerba Pharmaceuticals Inc are: Michael Rapp, James E Fickenscher, Armando Anido, Terri B Sebree, Brian Rosenberger, John P Butler, Kenneth T Jones, Daniel L Kisner, Pamela Stephenson, and Suzanne M Hanlon
The most active insider trader at Zynerba Pharmaceuticals Inc is Michael Rapp with 7 trades.
Armando Anido has sold the most Zynerba Pharmaceuticals Inc stock with a total value of $81,788.50.
Michael Rapp has bought the most Zynerba Pharmaceuticals Inc stock with a total value of $1,406,357.25.
The most recent insider trade for Zynerba Pharmaceuticals Inc was on Sept. 13, 2023.
The single biggest insider buy for Zynerba Pharmaceuticals Inc was from Michael Rapp with a total value of $424,405.45 on Oct. 19, 2017.
The single biggest insider sell for Zynerba Pharmaceuticals Inc was from Suzanne M Hanlon with a total value of $31,590.00 on Aug. 16, 2016.